ClearPoint Neuro (CLPT) Cash & Current Investments (2017 - 2026)
ClearPoint Neuro's Cash & Current Investments history spans 14 years, with the latest figure at $45.9 million for Q4 2025.
- On a quarterly basis, Cash & Current Investments rose 128.36% to $45.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $45.9 million, a 128.36% increase, with the full-year FY2025 number at $45.9 million, up 128.36% from a year prior.
- Cash & Current Investments hit $45.9 million in Q4 2025 for ClearPoint Neuro, up from $38.2 million in the prior quarter.
- Over the last five years, Cash & Current Investments for CLPT hit a ceiling of $64.9 million in Q1 2021 and a floor of $12.4 million in Q1 2025.
- Historically, Cash & Current Investments has averaged $38.2 million across 5 years, with a median of $37.8 million in 2022.
- Biggest five-year swings in Cash & Current Investments: soared 293.12% in 2021 and later tumbled 64.96% in 2025.
- Tracing CLPT's Cash & Current Investments over 5 years: stood at $54.1 million in 2021, then tumbled by 30.68% to $37.5 million in 2022, then plummeted by 38.4% to $23.1 million in 2023, then decreased by 12.99% to $20.1 million in 2024, then surged by 128.36% to $45.9 million in 2025.
- Business Quant data shows Cash & Current Investments for CLPT at $45.9 million in Q4 2025, $38.2 million in Q3 2025, and $41.5 million in Q2 2025.